Three new benzophenone glycosides with MAO-A inhibitory activity from Hypericum thasium Griseb.

Phytochemistry Letters

Volumn 5, Issue 4, 2012, Pages 700-704

  Demirkiran, Ozlem ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Antidepressants; Benzophenone glycosides; Hypericum thasium Griseb.; MAO A

Indexed keywords

3',4 DIHYDROXY 5' METHOXY 2 O ALPHA ARABINOSYL 6 O BETA XYLOSYLBENZOPHENONE; 3',4,5' TRIHYDROXY 6 METHOXY 2 O ALPHA ARABINOSYLBENZOPHENONE; 3',4,5',6 TETRAHYDROXY 2 O ALPHA ARABINOSYLBENZOPHENONE; BENZOPHENONE; CLORGYLINE; GLYCOSIDE; KAEMPFEROL; MONOAMINE OXIDASE A INHIBITOR; QUERCETIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; HYPERICUM THASIUM; IC 50; MEDICINAL PLANT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

HYPERICUM;

EID: 84869500753     PISSN: 18743900     EISSN: 18767486     Source Type: Journal    
DOI: 10.1016/j.phytol.2012.06.018     Document Type: Article

References (28)

1. P.K. Agrawal NMR spectroscopy in the structural elucidation of oligosaccharides and glycosides Phytochemistry 31 1992 3307 3330
2. K.O. Aley, and S.K. Kulkarni GABAergic agents and clonidine attenuate footshock-induced aggression in mice Methods Find. Exp. Clin. Pharmacol. 11 1989 597 601
3. 13C NMR Can. J. Chem. 58 1980 2800 2804
4. J.A. Bodkin, and J.D. Amsterdam Transdermal selegiline in major depression: a double-blind placebo-controlled parallel-group study in outpatients Am. J. Psychiatr. 159 2002 1869 1875 (Pubitemid 35283252)
5. F. Chimenti, F. Cottiglia, L. Bonsignore, L. Casu, M. Casu, C. Floris, D. Secci, A. Bolasco, P. Chimenti, A. Granese, O. Befani, P. Turini, S. Alcaro, F. Ortuso, G. Trombetta, A. Loizzo, and I. Guarino Quercetin as the active principle of hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study J. Nat. Prod. 69 2006 945 949 (Pubitemid 44166270)
6. O. Demirkiran, M.A. Mesaik, H. Beynek, A. Abbaskhan, and M.I. Choudhary Cellular reactive oxygen species inhibitory constituents of Hypericum thasium Griseb. Phytochemistry 70 2009 244 249
7. G. Di Carlo, F. Borrelli, E. Ernst, and A.A. Izzo St. John's wort: Prozac from the plant kingdom Trends Pharmacol. Sci. 22 2001 292 297 (Pubitemid 32523912)
8. C.A.J. Erdelmeier, E. Koch, and R. Hoerr Hypericum perforatum - St. John's wort chemical pharmacological and clinical aspects A. Rahman, Studies in Natural Products Chemistry-Bioactive Natural Products, vol. 22, Part C 2000 Elsevier Direct New York 643 716
9. F. Gaedcke St. John's wort herb extracts: manufacturing, standardization and characterization E. Ernst, Hypericum, Medicinal and Aromatic Plants - Industrial Profiles 2003 Taylor and Francis Group London 49 64 Chapter 4
10. 13C magnetic resonance spectra of aldoses and derived methyl glycosides Can. J. Chem. 53 1975 1212 1223
11. G. Harrer, W.D. Hübner, and H. Podzuweit Effectiveness and tolerance of the Hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study J. Geriatr. Psychiatry Neurol. 7 1994 24 28
12. G. Harrer, U. Schmidt, U. Kuhn, and A. Biller A comparison of equivalence between St. John's wort extract Lottyp-57 and fluoxetine Arzneimittel- Forschung. 49 1998 3 10
13. X.H. Han, S.S. Hong, J.S. Hwang, M.K. Lee, B.Y. Hwang, and J.S. Ro Monoamine oxidase inhibitory components from Cayratia japonica Arch. Pharm. Res. 30 2007 13 17
14. A. Holt, D.S. Sharman, G.B. Baker, and M.M. Palcic A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates Anal. Biochem. 244 1997 384 392 (Pubitemid 27043336)
15. L.H. Hu, S.C. Yip, and K.Y. Sim Xanthones from Hypericum ascyron Phytochemistry 52 1999 1371 1373
16. J.P. Johnston Some observations upon a new inhibitor of monoamine oxidase in brain tissue Biochem. Pharmacol. 17 1968 1285 1297
17. K. Linde, and C.D. Mulrow St. John's wort for depression Cochrane Database Syst. Rev. 2 2000 CD000448
18. M.B. Núñez, F.P. Maguna, N.B. Okulik, and E.A. Castro QSAR modelling of the MAO inhibitory activity of xanthone derivatives Bioorg. Med. Chem. Lett. 14 2004 5611 5617 (Pubitemid 39346355)
19. M. Philipp, R. Kohnen, and K.O. Hiller Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks BMJ 319 1999 1534 1538
20. L. Saaby, H.B. Rasmussen, and A.K. Jäger MAO-A inhibitory activity of quercetin from Calluna vulgaris L. Hull. J. Ethnopharmacol. 121 2009 178 181
21. J. Saura Marti, R. Kettler, M. Da Prada, and J.G. Richards Molecular neuroanatomy of MAO-A and MAO-B J. Neural. Transm.-Supp. 32 1990 49 53
22. W. Schmidt, A.M.A. Abd EI-Mawla, J.L. Wolfender, K. Hostettmann, and L. Beerhues Xanthones in cell cultures of Hypericum androsaemum Planta Med. 66 2000 380 381 (Pubitemid 30346310)
23. M.D. Shan, L.H. Hu, and Z.L. Chen Three new hyperforin analogues from Hypericum perforatum J. Nat. Prod. 64 2001 127 130 (Pubitemid 32107798)
24. B.D. Sloley, L.J. Urichuk, P. Morley, J. Durkin, J.J. Shan, P.K. Pang, and R.T. Coutts Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of ginkgo biloba leaves J. Pharm. Pharmacol. 52 2000 451 459 (Pubitemid 30223690)
25. G.I. Stafford, P.D. Pedersen, A.K. Jager, and J. Van Standen MAO inhibition by southern African traditional medicinal plants S. Afr. J. Bot. 73 2007 384 390 (Pubitemid 47126096)
26. E.U. Vorbach, W.D. Hübner, and K.H. Arnoldt Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients J. Geriatr. Psychiatry Neurol. 7 1994 19 23
27. D. Wheatley LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients, a controlled 6-week clinical trial Pharmacopsychiatry 30 1997 77 80
28. M. Yamada, and H. Yasuhara Clinical pharmacology of MAO inhibitors: safety and future Neurotoxicology 25 2004 215 221 (Pubitemid 38044183)